Skip to content

Study · Ex vivo tissue · mouse · 2005

1 result

Peptide-mediated protection from ethanol-induced neural tube defects.

Chen SY, Charness ME, Wilkemeyer MF, Sulik KK

Developmental neuroscience1 Jan 2005Cited by 44 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueEfficacy outcome

    In mouse embryo cultures exposed to ethanol, L-NAP significantly increased the percentage that reached the reported neural fold closure stages.

    In plain wordsIn lab tests with mouse embryos exposed to ethanol, L-NAP increased the percentage that reached the reported neural fold closure stages.

    Peptide
    Davunetide
    Outcome
    IncreaseNeural fold closure
    Study

    mousen: not reported in source

    C57BL/6J whole embryo culture
    Comparator
    Ethanol exposure
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    10(-10) M · 6 h exposure followed by 20 h in control mediumAs given in this study (mouse).

    Source sentences

    Summary
    Co-incubation with ethanol and L-NAP (all L-amino acids), D-NAP (all D-amino acids) or SAL significantly increased the percentage of embryos that had begun to close their neural folds at the level of the forebrain/midbrain junction or that had progressed beyond this stage of closure.
    2 context sentences
    Summary · context
    Gestational day 8.0 (3-5 somites) C57BL/6J mouse embryos were grown for 6 h in control medium, 100 mM ethanol and 10(-10) M peptides and then maintained for an additional 20 h in control medium.
    Summary · context
    At the end of the culture period, only embryos having 18-19 somite pairs were examined and compared for the degree of neural tube closure.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.